WEI-WU CHENCHING-HUNG LINYEN-SHEN LU2022-03-152022-03-1520162218-676Xhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84992153778&doi=10.21037%2ftcr.2016.08.27&partnerID=40&md5=970928daa4ff8eeaf2f33a0b017b83a4https://scholars.lib.ntu.edu.tw/handle/123456789/597556[SDGs]SDG3cyclophosphamide; epirubicin; fluorouracil; tamoxifen; breast cancer; cancer adjuvant therapy; cancer hormone therapy; cancer staging; cancer survival; disease free survival; Editorial; estrogen synthesis; female; human; premenopause; treatment outcomeeditorial10.21037/tcr.2016.08.272-s2.0-84992153778